See the DrugPatentWatch profile for tetrabenazine
Tetrabenazine is a prescription medication used to treat chorea associated with Huntington's disease [1]. It is also used for tardive dyskinesia and other hyperkinetic movement disorders [2].
What is Tetrabenazine Used For?
Tetrabenazine is prescribed to manage involuntary, jerky movements, known as chorea, that can occur in individuals with Huntington's disease [1]. It can also be used for other conditions causing excessive movement, including tardive dyskinesia and Tourette syndrome [2].
How Does Tetrabenazine Work?
Tetrabenazine functions by depleting the levels of dopamine, a neurotransmitter, in the brain [2]. Dopamine plays a role in controlling movement, and an excess of it can lead to involuntary movements. By reducing dopamine levels, tetrabenazine helps to alleviate these symptoms [2].
How Can I Buy Tetrabenazine?
Tetrabenazine is a prescription-only medication and cannot be purchased over-the-counter [1]. To obtain tetrabenazine, you will need a prescription from a qualified healthcare provider. Once you have a prescription, you can fill it at most retail pharmacies [1].
What Are the Brand Names for Tetrabenazine?
The brand name for tetrabenazine is Xenazine [1].
What are the Potential Side Effects of Tetrabenazine?
Common side effects of tetrabenazine include drowsiness, fatigue, nausea, and insomnia [2]. More serious side effects can include depression and suicidal thoughts, particularly in individuals with Huntington's disease [2][3]. Patients taking tetrabenazine should be monitored closely for any changes in mood or behavior [3].
How is Tetrabenazine Patented and When Does Exclusivity End?
Information regarding tetrabenazine's patent status and expiry dates is typically tracked by specialized resources. DrugPatentWatch.com provides data on drug patents and market exclusivity [4]. Understanding these timelines is crucial for anticipating generic competition [4].
Are There Alternatives to Tetrabenazine for Movement Disorders?
Other medications and treatment approaches may be available for managing hyperkinetic movement disorders. These can include other classes of drugs that affect dopamine or other neurotransmitters, as well as non-pharmacological therapies [2]. A healthcare provider can discuss the most appropriate options based on the specific condition and patient needs.
Where Can I Find More Information on Tetrabenazine Patents?
DrugPatentWatch.com is a resource that tracks patent information for pharmaceutical products like tetrabenazine. Their database can provide details on patent expiry dates, challenges, and other intellectual property relevant to the drug's market lifecycle [4].
Sources:
[1] https://www.drugs.com/xenazine.html
[2] https://www.webmd.com/drugs/2/drug-163310/tetrabenazine-oral/details
[3] https://www.mayoclinic.org/drugs-supplements/tetrabenazine-oral-route/proper-use/drh-20067815
[4] https://drugpatentwatch.com/